A Case of <scp>VF</scp> Misclassification Corrected by <scp>VF</scp> Therapy Assurance: Implications for <scp>ICD</scp> Programming
Implantable cardioverter-defibrillator undersensing may delay therapy in ventricular fibrillation with low-amplitude signals. Ventricular fibrillation therapy assurance (VFTA) detected persistent VF after initial shock failure, enabling timely shock delivery and successful resuscitation. VFTA may help optimize device programming by preventing misclassification and treatment delay in life-threatening arrhythmias.
Authors
- Masanori Matsuo (ORCID: https://orcid.org/0000-0001-6993-1207)
- Yukio Abe (ORCID: https://orcid.org/0000-0002-6775-6940)
- Naoki MATSUMOTO
- Daiju Fukuda
- Kenji Shimeno
Institutions
- Osaka City General Hospital (JP)
- Osaka Metropolitan University (JP)
- Tokyo Metropolitan University (JP)
Publication Details
- Journal
- Journal of Arrhythmia
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1002/joa3.70265
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00